Aims. With increasing burden of
The aim of this study was to systemically review the evidence for the use of intra-operative cell salvage (ICS) among patients undergoing
The rising prevalence of osteoarthritis, associated with an ageing population, is expected to deliver increasing demand across Scotland for arthroplasty services in the future. Understanding the scale of potential change to operative workflow is essential to ensure adequate provision of services and prevent prolonged waiting times that can cause patient harm. This future service demand for primary and
Total hip arthroplasty (THA) has proved to be an effective treatment modality for sickle-cell hip arthropathy (mosaic-like dense bone due to infarcts). However, mode of failure, survival rates and challenges associated with
The management of severe acetabular bone defects poses a complex challenge in
Aims. This study describes the variation in the annual volumes of
Introduction. Patients with osteonecrosis of the femoral head are typically younger, more active, and often require high rates of revision following primary total hip arthroplasty. However, outcomes of
Chronic pelvic discontinuity (CPD) during
Introduction There are no reports on the epidemiology of
Revision of the femoral component during
This study was performed to assess the relationship between patients’ pre-operative symptoms and their expectations at the time of
This study evaluates the association between consultant and hospital volume and the risk of re-revision and 90-day mortality following first-time revision of primary hip replacement for aseptic loosening. We conducted a cohort study of first-time, single-stage
Introduction: The purpose of this study was to assess the efficacy and complications associated with
Introduction. Previous reports have investigated the correlation between time to
Aim: To evaluate the medium term results of
Aim: We audited medical complications after
Introduction &
Aims:
Introduction. The aim of this study is to report the results of
Aim We have prospectively investigated the effect of tranexamic acid in reducing blood loss and transfusion requirements in primary and revision total hip arthroplasty in a comparative study. Patients and Methods In the study group, tranexamic acid was given half an hour before the skin incision. (10 mg/kg as an intravenous bolus, followed by 10 mg/kg as intravenous infusion over 6 hours). We recorded the haemoglobin level preoperatively and prior to discharge, and number of units of blood transfused. The total peri-operative blood loss and the fall in haemoglobin after surgery was calculated in consultation with our haematologist. There were 9 primary and 17
Revision of the femoral component during